• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    WDSrx Expands Warehouse Network

    Piramal Inks Clinical Supply Deal with Theratechnologies

    Recipharm Signs Manufacturing Deal with Enzymatica

    CDMO Northway Biotech Expands in U.S.

    Global Biosciences Co. Selects ValGenesis VLMS
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    WDSrx Expands Warehouse Network

    Piramal Inks Clinical Supply Deal with Theratechnologies

    Recipharm Signs Manufacturing Deal with Enzymatica

    CDMO Northway Biotech Expands in U.S.

    Lonza to Exit Pharma Softgels and Liquid-Filled Hard Capsules
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    WDSrx Expands Warehouse Network

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Improving Product Profitability

    CDMO Northway Biotech Expands in U.S.

    Global Biosciences Co. Selects ValGenesis VLMS

    Nexelis Acquires GSK Vax Lab in Marburg

    The Future of Clinical Trials Series: Part I
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    PCI Pharma Services

    Emergent BioSolutions

    Syngene

    Adare Pharma Solutions

    Baxter BioPharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami

    Syngene

    Reed-Lane

    Emergent BioSolutions

    Cytovance Biologics
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    A Brave New World of Data Integrity

    How modern CMOs are keeping up with stringent regulatory guidelines by embracing advanced laboratory information systems.

    A Brave New World of Data Integrity
    Related CONTENT
    • Asymchem
    • Mogene
    • Vetio Animal Health
    • The 20th Annual Salary Survey
    • Serialization and the Rest of Us
    Bob Voelkner, VP Sales and Marketing, LabVantage06.13.19
    It’s a good time to be a contract manufacturing organization (CMO). Pharmaceutical and biotechnology companies, in a race to stay competitive and impact more patients, are choosing to focus heavily on research and development activities, with little left over for on-premise manufacturing. This means that CMOs are in high demand, and the products they’re manufacturing are more diverse and complex than ever.

    This wave of opportunity has ushered with it an era of heightened regulatory scrutiny, particularly in relation to data integrity. The manual record-keeping practices that once satisfied regulators simply aren’t keeping up. Today’s auditors, sensitive to a recent uptick in infractions, expect broader access and more transparency from CMOs, with a particular emphasis on changes made in temporary memory.

    In order to withstand this intensifying pressure while improving operational efficiencies, CMOs large and small are sunsetting their traditional data management workflows in favor of digital tools specially designed to ensure that data are complete, consistent, enduring, and available.

    The pressure is on
    In 2016, after reporting an overall increase in offenses related to poor data management practices and inconsistent documentation, the U.S. Food and Drug Administration (FDA) issued its Data Integrity and Compliance with CGMP Guidance for Industry. The European Medicines Agency (EMA), the UK Medicines and Healthcare Products Regulatory Agency (MHRA), and the World Health Organization (WHO) also issued new or updated guidelines during this period. Under the auspices of 21 CFR 11 and Annex 11, these updates reflect a notably higher standard of quality for the practices governing data integrity in QC and manufacturing labs.

    In order to meet this elevated standard, CMOs around the world are rallying behind the principle that all data should be attributable, legible, contemporaneous, original, and accurate (qualities known by the acronym ALCOA), as well as consistent, available, enduring, and complete (ALCOA+). The concepts captured by that appended “plus” symbol are about giving a datum context, especially during future reviews and audits. In other words, ALCOA+ sets an expectation that CMOs can and will disclose a complete picture of data throughout its entire lifecycle.

    As part of this expectation, the FDA has swung its spotlight toward a concept that, until relatively recently, had been widely accepted in the industry: the idea that data isn’t really data until and unless it’s saved. That moment—an analyst clicks “Save,” committing a datum to durable media—is the bright line dividing “temporary” from “enduring.” In its temporary state, data can be manipulated multiple times, either accidentally or (in rare cases) intentionally, since it has not been committed to durable media. A mistype can be fixed, a value corrected, or, as regulators fear, a noncompliant result deliberately changed in order to meet specifications, all without detection. As long as an audit only reveals the “enduring” state, regulators worry that an important piece of the story—a piece that could reveal bad behavior or a dangerous oversight—is missing. In order to strengthen the audit trail and encourage the retention of all necessary information, the FDA and other agencies around the world now recommend that CMOs capture all data, including data that has been entered but not saved.

    This principle of dynamic auditing—that is, tracking changes to temporary data—has become a cornerstone theme of modern integrity standards, and it’s driving significant change in the way that CMOs manage their data.

    What’s at stake for the CMO?
    This world of greater data integrity, in which all activity in a dataset is subject to inspection, brings with it the possibility of severe consequences for those who are unable or unwilling to adapt.

    When an infraction is discovered, regulators typically begin by issuing warning letters and Form 483 citations. If caught in the cross-hairs of such a warning, CMOs, already under pressure to narrow their margins as much as possible, can face costly fines with devastating consequences to their bottom line. They may even be placed under a consent decree, which could prohibit them from manufacturing, holding or distributing products until they achieve regulatory compliance. Rebounding from such an injunction can be very difficult.

    Consent decrees are rare. But even a warning letter can trigger a negative spiral for CMOs, who operate in a competitive world where new business is often won and lost on the strength of reputation. A CMO carrying a data integrity infraction on its record is a CMO with diminished hope of survival.

    Even in scenarios where data management is sub-par but not subject to official sanctions, CMOs face expensive consequences. For example, if the amount of product in a bottle relies on potency, an incorrect potency value could cost the company money when a bottle is overfilled (contributing to a reduced yield) or not filled enough (making it necessary to reprocess products). These mistakes accumulate quickly, often with significant financial fallout.

    Staying out of trouble and maintaining a polished reputation are, of course, important. But for all responsible CMOs, protecting consumer health is what matters most of all, and intensified data integrity standards are, after all, designed to service the safety, efficacy, and quality of the world’s pharmaceutical supply. By maintaining compliance, CMOs aren’t just ensuring their own longevity in the marketplace; they’re also preserving product quality and availability for the patients who rely on their output.  

    In order to maintain compliance while preserving this level of supreme quality and product consistency, many CMOs are modernizing their data-related practices with the introduction of advanced laboratory information management systems (LIMS).

    What the modern CMO knows about LIMS
    Manual, paper-based record-keeping, once the mainstay of CMOs, is facing obsolescence. More and more labs are migrating away from the porous nature of this traditional approach, in which integrity is lost with each transcription error, each small deviation in standard procedure, each frog-leap from one siloed system to another.

    Efficiency is lost in traditional systems, too. Each manual task takes time. Time, especially in a market defined by tight margins and close competition, is money. Without improvements to their operational efficiency—and with their data subject to the errors and inconsistencies of manual record-keeping—CMOs risk falling behind their competitors. To avoid this fate, many CMOs are embracing an advanced generation of software-enabled electronic platforms to govern their data collection practices.

    CMOs aren’t alone in their mass migration away from manual tasks. In all areas of manufacturing, from pharmaceutical labs to car assembly plants, companies are using programmable software to take over the tasks that humans aren’t especially good at (or inclined to do). The result is a tech-enabled workflow that’s many times as efficient, and far more consistent, than a manual approach. Think of industrial automation, for example: guided by software that never deviates from its preconfigured objective, a robotic arm can screw eight thousand nuts onto eight thousand bolts with total consistency. Each nut will be turned the same number of revolutions, with the same torque, producing the same verifiable result every time. Not so in the hands of even the most diligent human worker.

    In a CMO, this level of stability and consistency begins with the adoption of a LIMS platform. The robotic arm that never stops working on the factory floor becomes the database that never stops refreshing itself in the LIMS-enabled CMO. This allows analysts to displace the burden of diligent, consistent record-keeping onto a system far more suited to its granularity and complexity, and far more resistant to error.

    LIMS pull in data automatically, through mobile devices, hand-held scanners and lab instrumentation that interfaces directly with the software, signaling the end of a problematic era in which analysts transcribed data by hand from instrument readouts, or observed and recorded test results themselves. It also introduces a new layer of impartiality in a CMO’s record-keeping system, because LIMS possess none of the complicated moral ambiguity that, in humans, can very occasionally lead to “creative” record-keeping. By contrast, a LIMS platform is neutral, inexhaustible, and fanatically consistent.

    How LIMS improves overall data management
    Purpose-built to meet specific lab functions, a LIMS platform offers what manual systems never could: a way to capture, organize, and analyze data consistently, automatically, and across multiple sites. Every activity benefits from this level of automation. Undertaking a routine workflow, for example, would once have required lab workers to interpret and follow paper-based protocols. Like 10 different chefs following the same recipe in 10 different kitchens, this would naturally lead to inconsistencies in execution—10 different cakes.

    Not so with a LIMS platform in place, which enforces consistency, and even interfaces directly with lab instrumentation to ensure it’s precisely configured according to specific assay parameters. The result is a consistent and reproducible workflow, with a predictable result, time after time.

    In an era when many CMOs are growing their global footprint through acquisition, this enforced consistency is especially valuable. Centrally hosted and globally accessible to authorized users, a LIMS platform offers the secure accessibility that geographically diverse sites need. It enforces process. It upholds standardization. And because it can pull data directly from connected instruments without relying on the accuracy of manual transcription, it provides continuous protection against quality-related risks.

    The ubiquity of a well-deployed LIMS platform helps not just in connecting remote sites, but in connecting diverse functions, too. Some advanced LIMS allow users to turn on Electronic Laboratory Notebook (ELN) and Laboratory Execution System (LES) functionality. In a traditional workflow, data would have to jump between these different systems via a paper-based chain of custody. Each jump would introduce a new possibility for error. In a modern LIMS platform, which integrates ELN and LES functions in a single uninterrupted workflow, each datum is stored exactly once and shared across the whole system. Fewer jumps, fewer opportunities for error.

    Such a high degree of integration also introduces new and in-depth searchability across complex CMO networks. With fewer siloes barricading data in fragmented clusters, and greater transparency throughout every step in a workflow, CMOs can locate and recall a detailed history of each event, whether from last month or last year. And because users interact with the LIMS platform under unique and authenticated identifiers, lab managers know with precision who entered what datum, and when. This means that they can track any irregular activities—like multiple repetitions of the same test—with a high degree of transparency, further ensuring regulatory compliance.

    Ensuring no data is forgotten
    While one of the greatest advantages of the LIMS platform is its ability to interface directly with instrumentation, every CMO still requires some degree of manual data capture, depending on the interoperability of a lab’s incumbent systems and instruments. In this case, too, the LIMS platform is invaluable as a vigilant partner for the human worker. For example, CMOs can configure their LIMS to recognize an accidental keystroke or a dropped digit. This means that users will get a prompt if, say, they’ve entered an “impossible” datum, like a pH value of 15 or a negative value for weight. Before they can proceed to their next step, they must correct that error, which helps to protect the database from inconsistencies.

    Such manual corrections are, of course, the stuff of temporary data, now within the purview of regulatory oversight. The most advanced LIMS platforms play a crucial role here, too. They’re designed to automatically capture any datum entered but not saved, and to require a reason for any changes made in temporary memory. Some LIMS even include a visual flag in the permanent data trail, signalling the presence of underlying temporary data available for review.

    The result is a clean, transparent, GxP-compliant audit trail based on the full history of a test.

    Conclusions
    As the pharmaceutical and biotechnology industries race to develop ever more advanced and complex chemical entities, pressure is growing on individual CMOs to operate more productively, cost-effectively, and safely than the next competitor. Watching over this crowded landscape is the ever-widening aperture of the industry’s regulatory alphabet: the FDA, the EMA, the MHRA, and the WHO. Their guidelines for data integrity, newly refreshed for the modern world of data collection, demand more transparency and accuracy than ever before.
    As these pressures accumulate, modern CMOs must abandon their traditional, paper-based record-keeping practices in favor of preconfigured, pre-validated LIMS built specifically for the needs of today’s pharmaceutical manufacturers. 


    Bob Voelkner is vice president of sales and marketing, Americas, LabVantage Solutions.
    Related Searches
    • acquisition
    • quality
    • patients
    • software
    Suggested For You
    Asymchem Asymchem
    Mogene Mogene
    Vetio Animal Health Vetio Animal Health
    The 20th Annual Salary Survey The 20th Annual Salary Survey
    Serialization and the Rest of Us Serialization and the Rest of Us
    FDA Inspection of Asymchem Dunhua 1 API Manufacturing Facility is Successful FDA Inspection of Asymchem Dunhua 1 API Manufacturing Facility is Successful
    Central Pharma Partners with Veratrak Central Pharma Partners with Veratrak
    FDA Approves TraceLink DSCSA Pilot Submission for Network Solutions FDA Approves TraceLink DSCSA Pilot Submission for Network Solutions
    Nitrosamines Nitrosamines
    Process Validation in Biologics Development Process Validation in Biologics Development
    WuXi Biologics Completes First FDA Routine GMP Inspection WuXi Biologics Completes First FDA Routine GMP Inspection
    Pii Receives EIR From FDA Pii Receives EIR From FDA
    WuXi AppTec Testing Facilities Complete Inspections WuXi AppTec Testing Facilities Complete Inspections
    2019 Trends & Predictions 2019 Trends & Predictions
    Former FDA Senior Executives Join PAREXEL Former FDA Senior Executives Join PAREXEL

    Related Features

    • Clinical Trials | Information Technology | R&D
      Decentralized Trials Fuel AI Revolution in Clinical Research

      Decentralized Trials Fuel AI Revolution in Clinical Research

      The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.
      Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20

    • Clinical Trials | Information Technology
      The Role of Electronic Monitoring in Maintaining Medication Adherence

      The Role of Electronic Monitoring in Maintaining Medication Adherence

      Digital solutions offer hope to get patients to take their medications properly.
      Bernard Vrijens, Scientific Lead, AARDEX Group 10.14.20

    • Information Technology
      You Need Solutions, Digitization is the Answer

      You Need Solutions, Digitization is the Answer

      Cloud technology helps today’s contract manufacturers be agile, transparent and efficient.
      Brian Curran, Senior Vice President of Strategic Growth, MasterControl 10.14.20


    • Information Technology
      Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

      Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

      The proven promise and huge potential of using AI and ML to accelerate drug discovery.
      Lucas Glass, Gary Shorter, and Rajneesh Patil, IQVIA 11.20.19

    • Clinical Trials | Information Technology
      The New Horizon: Metaprise Analytics in Life Sciences

      The New Horizon: Metaprise Analytics in Life Sciences

      Going beyond enterprise analytics to metaprise analytics—patient-centric systems that create a data driven trial team.
      Michelle Longmire, MD, CEO and Founder, Medable 05.07.19

    • Information Technology
      The Manufacturing Revolution In Medicine

      The Manufacturing Revolution In Medicine

      Real-time data insights help both pharma companies and contract manufacturers meet regulatory requirements while ensuring high production standards.
      Petter Moree, OSIsoft, LLC 05.07.19


    • Information Technology
      Industry 4.0 in the Pharma Industry

      Industry 4.0 in the Pharma Industry

      Digitization is not a single-handed project.
      Dr. Christian Hanisch, Project Manager Industry 4.0 Pharma, Bosch Packaging Technology 03.06.19

    • Information Technology
      Digitization: Pharma 4.0

      Digitization: Pharma 4.0

      A look at how technology is impacting the pharma industry
      Fatih Kaya and Gerald Buerkle, Vetter Pharma 01.25.19

    • Information Technology
      FDA & Data Integrity

      FDA & Data Integrity

      FDA Publishes Final Guidance on Data Integrity
      Robert Marohn, Director of Quality Business Systems, Kite Pharmaceutical 01.25.19


    • Information Technology | Serialization | Supply Chain
      Serialization Compliance

      Serialization Compliance

      Automated data controls during packaging help improve compliance.
      Miguel Pitarch, Executive Director, Global Serialization, Bristol-Myers Squibb & the Bristol-Myers Squibb Serialization Team 11.13.18

    • Clinical Trial Materials | Information Technology
      Interactive Response Technology in Clinical Trial Supply

      Interactive Response Technology in Clinical Trial Supply

      Exploring the benefits of including IRT professionals earlier in trial planning
      Dave Holly, Senior Manager, IRT Development and Operations, Sharp Clinical Services 10.10.18

    • Drug Development | Information Technology | R&D
      CRO Industry Update: Big Data Drives Drug Development Efforts

      CRO Industry Update: Big Data Drives Drug Development Efforts

      With growth in virtual trials and RWE, the clinical development landscape may never look the same
      Kristin Brooks, Managing Editor 05.11.18


    • Information Technology | Serialization
      Stripping Serialization Back to Data Integrity

      Stripping Serialization Back to Data Integrity

      Why companies can’t afford to make compromises on quality
      Rachna Mohanka, Sr. Director, Global Solution Consulting, TraceLink 05.08.18

    • Information Technology | Regulatory Affairs
      Data Integrity: A Practical  and Risk-Based Approach

      Data Integrity: A Practical and Risk-Based Approach

      Ways an organization can form a culture and cost-effective means to meet the various challenges in sustaining data integrity.
      Robert Marohn, ClinLogic, LLC 09.06.17

    • Drug Delivery | Fill/Finish | Information Technology | Lyophilization | Serialization | Supply Chain | Vials
      Packaging Equipment Close-Up

      Packaging Equipment Close-Up

      To meet the wide-ranging needs of the marketplace, suppliers and contract packagers are looking to deliver flexible solutions.
      Kristin Brooks, Contract Pharma 03.09.16

    Trending
    • The Future Of Clinical Trials Series: Part I
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Lonza To Exit Pharma Softgels And Liquid-Filled Hard Capsules
    • Nexelis Acquires GSK Vax Lab In Marburg
    • CDMO Northway Biotech Expands In U.S.
    Breaking News
    • WDSrx Expands Warehouse Network
    • Piramal Inks Clinical Supply Deal with Theratechnologies
    • Recipharm Signs Manufacturing Deal with Enzymatica
    • CDMO Northway Biotech Expands in U.S.
    • Global Biosciences Co. Selects ValGenesis VLMS
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    Gadot Positions Mineral Line for Vegan Market
    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    TPI Partners with Zeiss
    PPE Moves into New Manufacturing Facility
    Neurent Medical Closes $25 Million Series B Financing
    Contract Pharma

    Latest Breaking News From Contract Pharma

    WDSrx Expands Warehouse Network
    Piramal Inks Clinical Supply Deal with Theratechnologies
    Recipharm Signs Manufacturing Deal with Enzymatica
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Lageen Tubes Launches Mono-Material PE Tube Solutions
    Jason Jones Loses Battle with Covid-19
    Weleda Celebrates 100 Years By 'Opening' Its Gardens
    Happi

    Latest Breaking News From Happi

    NY's 1,4-Dioxane Law May Impact Concentrated Cleaners
    Sabinsa's Top Scientist Addresses US FDA
    Ipsy Adds New Personal Care Brand
    Ink World

    Latest Breaking News From Ink World

    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    THIMM Group Installs 1st Koenig & Bauer CorruFLEX
    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Lemu Group engineers mask-making machine
    Niagara Label upgrades with Nilpeter flexo press
    Soma partners with Moore & Moore in US
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Lemu Group Engineers Mask-Making Machine
    Armbrust American Adds Meltblown Manufacturing
    P&G Reports 8% Sales Increase
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Siemens Healthineers’ DR Systems Cleared by FDA
    Former Medtronic Exec Appointed Zimmer Biomet's Chief Transformation Officer
    SeaSpine Launches Regatta Lateral Plates
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login